Gene: WBP4
Official Full Name: WW domain binding protein 4provided by HGNC
Gene Summary: This gene encodes WW domain-containing binding protein 4. The WW domain represents a small and compact globular structure that interacts with proline-rich ligands. This encoded protein is a general spliceosomal protein that may play a role in cross-intron bridging of U1 and U2 snRNPs in the spliceosomal complex A. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31097 | WBP4 Knockout cell line (HeLa) | Human | WBP4 | 1:3~1:6 | Negative | Online Inquiry |
KO31098 | WBP4 Knockout cell line (HCT 116) | Human | WBP4 | 1:2~1:4 | Negative | Online Inquiry |
KO31099 | WBP4 Knockout cell line (HEK293) | Human | WBP4 | 1:3~1:6 | Negative | Online Inquiry |
KO31100 | WBP4 Knockout cell line (A549) | Human | WBP4 | 1:3~1:4 | Negative | Online Inquiry |
WBP4 Gene Knockout Cell Lines are specially engineered cell lines characterized by the complete disruption of the WBP4 gene, a crucial component implicated in various biological processes, including signal transduction and cellular response mechanisms. Utilizing CRISPR-Cas9 technology, these cell lines are generated to facilitate detailed studies into the role of WBP4 in cell physiology and pathophysiology.
The functionality of WBP4 Gene Knockout Cell Lines lies in their ability to model the consequences of WBP4 deficiency. Researchers can observe changes in cellular behavior, including proliferation, apoptosis, and gene expression profiles, providing valuable insights into the molecular pathways influenced by WBP4. By enabling in-depth analysis of gene function, these knockout cell lines serve as an essential tool in elucidating the contributions of WBP4 to various diseases, including cancer and metabolic disorders.
The scientific importance of these cell lines extends to both research and clinical applications. They are pivotal in drug discovery, allowing scientists to evaluate therapeutic interventions targeting pathways associated with WBP4. Moreover, the insights gained from these studies can facilitate the development of novel biomarkers for disease prognosis and treatment responsiveness.
What sets WBP4 Gene Knockout Cell Lines apart from alternatives is their precision and specificity enabled by state-of-the-art gene editing techniques. This ensures a reliable model that minimizes off-target effects, thus providing confidence in the results. Furthermore, these cell lines are continuously validated and optimized for performance, affording users the highest quality in experimental reproducibility.
Researchers and clinicians will find immense value in utilizing WBP4 Gene Knockout Cell Lines, as they streamline experimental workflows and contribute to advancing scientific knowledge. By offering an accessible and efficient means to study gene function, they empower the scientific community to explore new frontiers in genetic research.
Our company, with its extensive background in molecular biology and dedication to innovation, is committed to providing advanced biological products like WBP4 Gene Knockout Cell Lines, meticulously designed to support and accelerate your research goals.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.